Role of the Nrf2-are pathway in liver diseases

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Shin, Sang Mi ^a   Yang, Ji Hye ^a   Ki, Sung Hwan ^a  

^a Chosun University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT CAPACITY; ANTIOXIDANT DEFENSE; ANTIOXIDANT RESPONSE ELEMENTS; BIOLOGICAL FUNCTIONS; HEPATOCELLULAR CARCINOMA; PATHOPHYSIOLOGY; TARGET GENE EXPRESSION; THERAPEUTIC TARGETS;

TRANSCRIPTION FACTORS;

DETOXIFICATION;

PARACETAMOL; TRANSCRIPTION FACTOR NRF2; PROTECTIVE AGENT;

ANTIOXIDANT RESPONSIVE ELEMENT; CHOLESTATIC HEPATITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER REGENERATION; LIVER TOXICITY; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION; VIRUS GENOME; VIRUS HEPATITIS; ANIMAL; GENETICS; METABOLISM;

ANIMALIA;

ANIMALS; ANTIOXIDANT RESPONSE ELEMENTS; HUMANS; LIVER DISEASES; LIVER REGENERATION; NF-E2-RELATED FACTOR 2; PROTECTIVE AGENTS; SIGNAL TRANSDUCTION;

EID: 84878703659     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/763257     Document Type: Review

References (82)

1. MacSween R. N. M., Anthony P. P., Scheuer P. J., Pathology of the Liver 1979 New York, NY, USA Churchill Livingstone. distributed in U.S. by Longman
2. Gershwin M. E., Vierling J. M., Manns M. P., Liver Immunology 2003 Philadelphia, Pa, USA Hanley & Belfus
3. Casarett L. J., Doull J., Klaassen C. D., Casarett and Doull's Toxicology: The Basic Science of Poisons 2008 7th New York, NY, USA McGraw-Hill
4. Zhu R., Wang Y., Zhang L., Guo Q., Oxidative stress and liver disease. Hepatology Research 2012 42 8 741 749
5. Mathers J., Fraser J. A., McMahon M., Saunders R. D. C., Hayes J. D., McLellan L. I., Antioxidant and cytoprotective responses to redox stress. Biochemical Society Symposium 2004 71 157 176 2-s2.0-16244385292 (Pubitemid 41185484)
6. Kobayashi M., Yamamoto M., Molecular mechanisms activating the Nrf2-Keap1 pathway of antioxidant gene regulation. Antioxidants and Redox Signaling 2005 7 3-4 385 394 2-s2.0-14044254798 10.1089/ars.2005.7.385 (Pubitemid 40279806)
7. Lee J. M., Li J., Johnson D. A., Stein T. D., Kraft A. D., Calkins M. J., Jakel R. J., Johnson J. A., Nrf2, a multi-organ protector? The FASEB Journal 2005 19 9 1061 1066 2-s2.0-21744445077 10.1096/fj.04-2591hyp (Pubitemid 40946431)
8. Kobayashi A., Kang M. I., Okawa H., Ohtsuji M., Zenke Y., Chiba T., Igarashi K., Yamamoto M., Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Molecular and Cellular Biology 2004 24 16 7130 7139 2-s2.0-3543008924 10.1128/MCB.24.16. 7130-7139.2004 (Pubitemid 39014439)
9. Zhang D. D., Lo S. C., Cross J. V., Templeton D. J., Hannink M., Keap1 is a redox-regulated substrate adaptor protein for a Cul3-dependent ubiquitin ligase complex. Molecular and Cellular Biology 2004 24 24 10941 10953 2-s2.0-10044228504 10.1128/MCB.24.24.10941-10953.2004 (Pubitemid 39603148)
10. Okawa H., Motohashi H., Kobayashi A., Aburatani H., Kensler T. W., Yamamoto M., Hepatocyte-specific deletion of the keap1 gene activates Nrf2 and confers potent resistance against acute drug toxicity. Biochemical and Biophysical Research Communications 2006 339 1 79 88 2-s2.0-28144445947 10.1016/j.bbrc.2005.10.185 (Pubitemid 41697517)
11. Vasiliou V., Qamar L., Pappa A., Sophos N. A., Petersen D. R., Involvement of the electrophile responsive element and p53 in the activation of hepatic stellate cells as a response to electrophile menadione. Archives of Biochemistry and Biophysics 2003 413 2 164 171 2-s2.0-0037447898 10.1016/S0003-9861(03)00095-X (Pubitemid 36506804)
12. Yeligar S. M., Machida K., Kalra V. K., Ethanol-induced HO-1 and NQO1 are differentially regulated by HIF-1 α and Nrf2 to attenuate inflammatory cytokine expression. Journal of Biological Chemistry 2010 285 46 35359 35373 2-s2.0-78149243703 10.1074/jbc.M110.138636
13. Hou J. K., Velayos F., Terrault N., Mahadevan U., Viral hepatitis and inflammatory bowel disease. Inflammatory Bowel Diseases 2010 16 6 925 932 2-s2.0-77952697076 10.1002/ibd.21284
14. Waris G., Siddiqui A., Regulatory mechanisms of viral hepatitis B and C. Journal of Biosciences 2003 28 3 311 321 2-s2.0-0037397156 (Pubitemid 36512806)
15. Lindenbach B. D., Rice C. M., Unravelling hepatitis C virus replication from genome to function. Nature 2005 436 7053 933 938 2-s2.0-23944476834 10.1038/nature04077 (Pubitemid 41191668)
16. Ozenirler S., Erkan G., Gulbahar O., Bostankolu O., Demirel O. O., Bilgihan A., Akyol G., Serum levels of advanced oxidation protein products, malonyldialdehyde, and total radical trapping antioxidant parameter in patients with chronic hepatitis C. Turkish Journal of Gastroenterology 2011 22 1 47 53 2-s2.0-79953836299 10.4318/tjg.2011.0156
17. Choi J., Ou J. H. J., Mechanisms of liver injury. III. Oxidative stress in the pathogenesis of hepatitis C virus. American Journal of Physiology 2006 290 5 G847 G851 2-s2.0-33645819203 10.1152/ajpgi.00522.2005
18. Gong G., Waris G., Tanveer R., Siddiqui A., Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF- B. Proceedings of the National Academy of Sciences of the United States of America 2001 98 17 9599 9604 2-s2.0-0035859871 10.1073/pnas.171311298 (Pubitemid 32769349)
19. Moriya K., Nakagawa K., Santa T., Shintani Y., Fujie H., Miyoshi H., Tsutsumi T., Miyazawa T., Ishibashi K., Horie T., Imai K., Todoroki T., Kimura S., Koike K., Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Research 2001 61 11 4365 4370 2-s2.0-0035360859 (Pubitemid 32685760)
20. Burdette D., Olivarez M., Waris G., Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway. Journal of General Virology 2010 91 3 681 690 2-s2.0-76849085285 10.1099/vir.0.014340-0
21. Ivanov A. V., Smirnova O. A., Ivanova O. N., Masalova O. V., Kochetkov S. N., Isaguliants M. G., Hepatitis C virus proteins activate NRF2/ARE pathway by distinct ROS-dependent and independent mechanisms in HUH7 cells. PLoS One 2011 6 9 e24957 10.1371/journal.pone.0024957
22. Carvajal-Yepes M., Himmelsbach K., Schaedler S., Ploen D., Krause J., Ludwig L., Weiss T., Klingel K., Hildt E., Hepatitis C virus impairs the induction of cytoprotective Nrf2 target genes by delocalization of small maf proteins. Journal of Biological Chemistry 2011 286 11 8941 8951 2-s2.0-79953220445 10.1074/jbc.M110.186684
23. Dhakshinamoorthy S., Jaiswal A. K., Small Maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:Quinone oxidoreductase1 gene. Journal of Biological Chemistry 2000 275 51 40134 40141 2-s2.0-0034704137 10.1074/jbc.M003531200 (Pubitemid 32064640)
24. Benn J., Schneider R. J., Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proceedings of the National Academy of Sciences of the United States of America 1994 91 22 10350 10354 2-s2.0-0028135497 10.1073/pnas.91.22.10350 (Pubitemid 24328994)
25. Schaedler S., Krause J., Himmelsbach K., Carvajal-Yepes M., Lieder F., Klingel K., Nassal M., Weiss T. S., Werner S., Hildt E., Hepatitis B virus induces expression of antioxidant response element-regulated genes by activation of Nrf2. Journal of Biological Chemistry 2010 285 52 41074 41086 2-s2.0-78650383684 10.1074/jbc.M110.145862
26. Lee W. M., Drug-induced hepatotoxicity. The New England Journal of Medicine 2003 349 5 474 485 2-s2.0-0041342015 10.1056/NEJMra021844 (Pubitemid 36910027)
27. Lee W. M., Acetaminophen and the U.S. acute liver failure study group: lowering the risks of hepatic failure. Hepatology 2004 40 1 6 9 2-s2.0-3042738919 10.1002/hep.20293 (Pubitemid 38868915)
28. Ostapowicz G., Fontana R. J., Schioødt F. V., Larson A., Davern T. J., Han S. H. B., McCashland T. M., Shakil A. O., Hay J. E., Hynan L., Crippin J. S., Blei A. T., Samuel G., Reisch J., Lee W. M., Santyanarayana R., Caldwell C., Shick L., Bass N., Rouillard S., Atillasoy E., Flamm S., Benner K. G., Rosen H. R., Martin P., Stribling R., Schiff E. R., Torres M. B., Navarro V., McGuire B., Chung R., Abraczinskas D., Dienstag J., Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Annals of Internal Medicine 2002 137 12 947 954 2-s2.0-0037126649 (Pubitemid 35440240)
29. Patel M., Tang B. K., Kalow W., Variability of acetaminophen metabolism in caucasians and orientals. Pharmacogenetics 1992 2 1 38 45 2-s2.0-0026817108
30. Prescott L. F., Critchley J. A. J. H., The treatment of acetaminophen poisoning. Annual Review of Pharmacology and Toxicology 1983 23 87 101 2-s2.0-0020644943 (Pubitemid 13079368)
31. James L. P., Mayeux P. R., Hinson J. A., Acetaminophen-induced hepatotoxicity. Drug Metabolism and Disposition 2003 31 12 1499 1506 2-s2.0-0344412840 10.1124/dmd.31.12.1499 (Pubitemid 37466918)
32. Vermeulen N. P. E., Bessems J. G. M., Van de Straat R., Molecular aspects of paracetamol-induced hepatotoxicity and its mechanism-based prevention. Drug Metabolism Reviews 1992 24 3 367 407 2-s2.0-0026691008
33. Hinson J. A., Reid A. B., McCullough S. S., James L. P., Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species, and mitochondrial permeability transition. Drug Metabolism Reviews 2004 36 3-4 805 822 2-s2.0-7544222053 10.1081/DMR-200033494 (Pubitemid 39453075)
34. Muldrew K. L., James L. P., Coop L., McCullough S. S., Hendrickson H. P., Hinson J. A., Mayeux P. R., Determination of acetaminophen-protein adducts in mouse liver and serum and human serum after hepatotoxlc doses of acetaminophen using high-performance liquid chromatography with electrochemical detection. Drug Metabolism and Disposition 2002 30 4 446 451 2-s2.0-0036206777 10.1124/dmd.30.4.446 (Pubitemid 34263830)
35. Chan K., Han X. D., Kan Y. W., An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proceedings of the National Academy of Sciences of the United States of America 2001 98 8 4611 4616 2-s2.0-0035836698 10.1073/pnas.081082098 (Pubitemid 32295024)
36. Enomoto A., Itoh K., Nagayoshi E., Haruta J., Kimura T., O'Connor T., Harada T., Yamamoto M., High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicological Sciences 2001 59 1 169 177 2-s2.0-0035153227 10.1093/toxsci/59.1.169 (Pubitemid 32117993)
37. Reisman S. A., Csanaky I. I., Aleksunes L. M., Klaassen C. D., Altered disposition of acetaminophen in Nrf2-null and keap1-knockdown mice. Toxicological Sciences 2009 109 1 31 40 2-s2.0-65549114152 10.1093/toxsci/kfp047
38. Goldring C. E. P., Kitteringham N. R., Elsby R., Randle L. E., Clement Y. N., Williams D. P., McMahon M., Hayes J. D., Itoh K., Yamamoto M., Park B. K., Activation of Hepatic Nrf2 in Vivo by Acetaminophen in CD-1 Mice. Hepatology 2004 39 5 1267 1276 2-s2.0-2342613543 10.1002/hep.20183 (Pubitemid 38569048)
39. Aleksunes L. M., Scheffer G. L., Jakowski A. B., Pruimboom-Brees I. M., Manautou J. E., Coordinated expression of multidrug resistance-associated proteins (Mrps) in mouse liver during toxicant-induced injury. Toxicological Sciences 2006 89 2 370 379 2-s2.0-31144459322 10.1093/toxsci/kfi332 (Pubitemid 43125995)
40. Aleksunes L. M., Sliit A. M., Cherrington N. J., Thibodeau M. S., Klaassen C. D., Manautou J. E., Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride. Toxicological Sciences 2005 83 1 44 52 2-s2.0-12344322514 10.1093/toxsci/kfi013 (Pubitemid 40123329)
41. Roberts J. C., Phaneuf H. L., Szakacs J. G., Zera R. T., Lamb J. G., Franklin M. R., Differential chemoprotection against acetaminophen-induced hepatotoxicity by latentiated L-cysteines. Chemical Research in Toxicology 1998 11 11 1274 1282 2-s2.0-0031773510 10.1021/tx980027k (Pubitemid 28531547)
42. Aleksunes L. M., Goedken M., Manautou J. E., Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury. World Journal of Gastroenterology 2006 12 12 1937 1940 2-s2.0-33645996345
43. Copple I. M., Goldring C. E., Jenkins R. E., Chia A. J. L., Randle L. E., Hayes J. D., Kitteringham N. R., Park B. K., The hepatotoxic metabolite of acetaminophen directly activates the keap1-Nrf2 cell defense system. Hepatology 2008 48 4 1292 1301 2-s2.0-54449093352 10.1002/hep.22472
44. Ni H. M., Bockus A., Boggess N., Jaeschke H., Ding W. X., Activation of autophagy protects against acetaminophen-induced hepatotoxicity. Hepatology 2012 55 1 222 232
45. Ni H. M., Boggess N., McGill M. R., Liver-specific loss of Atg5 causes persistent activation of Nrf2 and protects against acetaminophen-induced liver injury. Toxicological Sciences 2012 127 2 438 450
46. Kay H. Y., Kim Y. W., Ryu D. H., Sung S. H., Hwang S. J., Kim S. G., Nrf2-mediated liver protection by sauchinone, an antioxidant lignan, from acetaminophen toxicity through the PKC δ -GSK3 β pathway. British Journal of Pharmacology 2011 163 8 1653 1665 2-s2.0-79960900078 10.1111/j.1476-5381.2010.01095.x
47. Kim Y. W., Ki S. H., Lee J. R., Lee S. J., Kim C. W., Kim S. C., Kim S. G., Liquiritigenin, an aglycone of liquiritin in Glycyrrhizae radix, prevents acute liver injuries in rats induced by acetaminophen with or without buthionine sulfoximine. Chemico-Biological Interactions 2006 161 2 125 138 2-s2.0-33646850088 10.1016/j.cbi.2006.03.008 (Pubitemid 43776630)
48. Reisman S. A., Aleksunes L. M., Klaassen C. D., Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Biochemical Pharmacology 2009 77 7 1273 1282 2-s2.0-61449208761 10.1016/j.bcp.2008.12.028
49. Reisman S. A., Buckley D. B., Tanaka Y., Klaassen C. D., CDDO-Im protects from acetaminophen hepatotoxicity through induction of Nrf2-dependent genes. Toxicology and Applied Pharmacology 2009 236 1 109 114 2-s2.0-61849160406 10.1016/j.taap.2008.12.024
50. Randle L. E., Goldring C. E. P., Benson C. A., Metcalfe P. N., Kitteringham N. R., Park B. K., Williams D. P., Investigation of the effect of a panel of model hepatotoxins on the Nrf2-Keap1 defence response pathway in CD-1 mice. Toxicology 2008 243 3 249 260 2-s2.0-37149039327 10.1016/j.tox.2007.10.011 (Pubitemid 50012425)
51. Xu W., Hellerbrand C., Köhler U. A., Bugnon P., Kan Y. W., Werner S., Beyer T. A., The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Laboratory Investigation 2008 88 10 1068 1078 2-s2.0-52649098886 10.1038/labinvest.2008.75
52. Lee S. K., Jo S. W., Jeon T. W., In H. J., Chun H. J., Ghee H. K., Dong J. L., Kim T. O., Lee E. S., Tae C. J., Hepatotoxic effect of 1-bromopropane and its conjugation with glutathione in male ICR mice. Archives of Pharmacal Research 2005 28 10 1177 1182 2-s2.0-27744583057 (Pubitemid 41634293)
53. Liu F., Ichihara S., Valentine W. M., Itoh K., Yamamoto M., Mohideen S. S., Kitohk J., Ichihara G., Increased susceptibility of Nrf2-Null Mice to 1-bromopropane-induced hepatotoxicity. Toxicological Sciences 2010 115 2 596 606 2-s2.0-77954067512 10.1093/toxsci/kfq075
54. Farombi E. O., Shrotriya S., Na H. K., Kim S. H., Surh Y. J., Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food and Chemical Toxicology 2008 46 4 1279 1287 2-s2.0-39149106003 10.1016/j.fct.2007.09.095 (Pubitemid 351258204)
55. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J., Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The Lancet 2009 373 9682 2223 2233 2-s2.0-67649116613 10.1016/S0140-6736(09)60746-7
56. Gong P., Cederbaum A. I., Nrf2 is increased by CYP2E1 in rodent liver and HepG2 cells and protects against oxidative stress caused by CYP2E1. Hepatology 2006 43 1 144 153 2-s2.0-33644790212 10.1002/hep.21004 (Pubitemid 43733601)
57. Lamlé J., Marhenke S., Borlak J., von Wasielewski R., Eriksson C. J. P., Geffers R., Manns M. P., Yamamoto M., Vogel A., Nuclear factor-eythroid 2-related factor 2 prevents alcohol-induced fulminant liver Injury. Gastroenterology 2008 134 4 1159 1168 2-s2.0-41349119138 10.1053/j.gastro.2008. 01.011 (Pubitemid 351451966)
58. Wu K. C., Liu J., Klaassen C. D., Role of Nrf2 in preventing ethanol-induced oxidative stress and lipid accumulation. Toxicology and Applied Pharmacology 2012 262 3 321 329
59. Yates M. S., Tran Q. T., Dolan P. M., Osburn W. O., Shin S., McCulloch C. C., Silkworth J. B., Taguchi K., Yamamoto M., Williams C. R., Liby K. T., Sporn M. B., Sutter T. R., Kensler T. W., Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Carcinogenesis 2009 30 6 1024 1031 2-s2.0-66749112860 10.1093/carcin/bgp100
60. Kim S., Sohn I., Ahn J. I., Lee K. H., Lee Y. S., Lee Y. S., Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 2004 340 1 99 109 2-s2.0-5444240778 10.1016/j.gene.2004.06.015 (Pubitemid 39360236)
61. Tanaka Y., Aleksunes L. M., Yeager R. L., Gyamfi M. A., Esterly N., Guo G. L., Klaassen C. D., NF-E2-related factor 2 inhibits lipid accumulation and oxidative stress in mice fed a high-fat diet. Journal of Pharmacology and Experimental Therapeutics 2008 325 2 655 664 2-s2.0-42449111723 10.1124/jpet.107.135822 (Pubitemid 351574806)
62. Chowdhry S., Nazmy M. H., Meakin P. J., Dinkova-Kostova A. T., Walsh S. V., Tsujita T., Dillon J. F., Ashford M. L. J., Hayes J. D., Loss of Nrf2 markedly exacerbates nonalcoholic steatohepatitis. Free Radical Biology and Medicine 2010 48 2 357 371 2-s2.0-72649103895 10.1016/j.freeradbiomed.2009.11. 007
63. Okada K., Warabi E., Sugimoto H., Nrf2 inhibits hepatic iron accumulation and counteracts oxidative stress-induced liver injury in nutritional steatohepatitis. Journal of Gastroenterology 2012 47 8 924 935
64. Sugimoto H., Okada K., Shoda J., Warabi E., Ishige K., Ueda T., Taguchi K., Yanagawa T., Nakahara A., Hyodo I., Ishii T., Yamamoto M., Deletion of nuclear factor-E2-related factor-2 leads to rapid onset and progression of nutritional steatohepatitis in mice. American Journal of Physiology 2010 298 2 G283 G294 2-s2.0-76749149157 10.1152/ajpgi.00296.2009
65. Joseph S. B., Laffitte B. A., Patel P. H., Watson M. A., Matsukuma K. E., Walczak R., Collins J. L., Osborne T. F., Tontonoz P., Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. Journal of Biological Chemistry 2002 277 13 11019 11025 2-s2.0-0037192797 10.1074/jbc.M111041200 (Pubitemid 34952859)
66. Schultz J. R., Tu H., Luk A., Repa J. J., Medina J. C., Li L., Schwendner S., Wang S., Thoolen M., Mangelsdorf D. J., Lustig K. D., Shan B., Role of LXRs in control of lipogenesis. Genes and Development 2000 14 22 2831 2838 2-s2.0-0034669171 10.1101/gad.850400
67. Kay H. Y., Kim W. D., Hwang S. J., Nrf2 inhibits LXRalpha-dependent hepatic lipogenesis by competing with FXR for acetylase binding. Antioxid Redox Signal 2011 15 8 2135 2146
68. Weerachayaphorn J., Cai S. Y., Soroka C. J., Boyer J. L., Nuclear factor erythroid 2-related factor 2 is a positive regulator of human bile salt export pump expression. Hepatology 2009 50 5 1588 1596 2-s2.0-72949095452 10.1002/hep.23151
69. Xu S., Weerachayaphorn J., Cai S. Y., Soroka C. J., Boyer J. L., Aryl hydrocarbon receptor and NF-E2-related factor 2 are key regulators of human MRP4 expression. American Journal of Physiology 2010 299 1 G126 G135 2-s2.0-77954379023 10.1152/ajpgi.00522.2010
70. Weerachayaphorn J., Mennone A., Soroka C. J., Harry K., Hagey L. R., Kensler T. W., Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine. American Journal of Physiology 2012 302 9 G925 G936
71. Okada K., Shoda J., Taguchi K., Maher J. M., Ishizaki K., Inoue Y., Ohtsuki M., Goto N., Sugimoto H., Utsunomiy H., Oda K., Warabi E., Ishii T., Yamamoto M., Nrf2 counteracts cholestatic liver injury via stimulation of hepatic defense systems. Biochemical and Biophysical Research Communications 2009 389 3 431 436 2-s2.0-70449713440 10.1016/j.bbrc.2009.08.156
72. Tan K. P., Wood G. A., Yang M., Ito S., Participation of nuclear factor (erythroid 2-related), factor 2 in ameliorating lithocholic acid-induced cholestatic liver injury in mice. British Journal of Pharmacology 2010 161 5 1111 1121 2-s2.0-77958517394 10.1111/j.1476-5381.2010.00953.x
73. Paumgartner G., Beuers U., Mechanisms of action and therapeutic efficacy of ursodeoxycholic acid in cholestatic liver disease. Clinics in Liver Disease 2004 8 1 67 81 2-s2.0-1642338852 10.1016/S1089-3261(03)00135-1 (Pubitemid 38373670)
74. Okada K., Shoda J., Taguchi K., Maher J. M., Ishizaki K., Inoue Y., Ohtsuki M., Goto N., Takeda K., Utsunomiya H., Oda K., Warabi E., Ishii T., Osaka K., Hyodo I., Yamamoto M., Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. American Journal of Physiology 2008 295 4 G735 G747 2-s2.0-57349108021 10.1152/ajpgi.90321.2008
75. Kawata K., Kobayashi Y., Souda K., Kawamura K., Sumiyoshi S., Takahashi Y., Noritake H., Watanabe S., Suehiro T., Nakamura H., Enhanced hepatic Nrf2 activation after ursodeoxycholic acid treatment in patients with primary biliary cirrhosis. Antioxidants and Redox Signaling 2010 13 3 259 268 2-s2.0-77954101086 10.1089/ars.2009.2903
76. Oh C. J., Kim J. Y., Min A. K., Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-beta/Smad signaling. Free Radical Biology & Medicine 2012 52 3 671 682
77. El-Serag H. B., Rudolph K. L., Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007 132 7 2557 2576 2-s2.0-34250020201 10.1053/j.gastro.2007.04.061 (Pubitemid 46890874)
78. Kitamura Y., Umemura T., Kanki K., Kodama Y., Kitamoto S., Saito K., Itoh K., Yamamoto M., Masegi T., Nishikawa A., Hirose M., Increased susceptibility to hepatocarcinogenicity of Nrf2-deficient mice exposed to 2-amino-3- methylimidazo[4,5-f]quinoline. Cancer Science 2007 98 1 19 24 2-s2.0-33751322162 10.1111/j.1349-7006.2006.00352.x (Pubitemid 44803915)
79. Bishayee A., Bhatia D., Thoppil R. J., Darvesh A. S., Nevo E., Lansky E. P., Pomegranate-mediated chemoprevention of experimental hepatocarcinogenesis involves Nrf2-regulated antioxidant mechanisms. Carcinogenesis 2011 32 6 888 896 2-s2.0-79958214540 10.1093/carcin/bgr045
80. Michalopoulos G. K., Liver regeneration. Journal of Cellular Physiology 2007 213 2 286 300 2-s2.0-34848864570 10.1002/jcp.21172 (Pubitemid 47509705)
81. Beyer T. A., Xu W., Teupser D., Auf Dem Keller U., Bugnon P., Hildt E., Thiery J., Kan Y. W., Werner S., Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. The EMBO Journal 2008 27 1 212 223 2-s2.0-38049055294 10.1038/sj.emboj.7601950
82. Wakabayashi N., Shin S., Slocum S. L., Agoston E. S., Wakabayashi J., Kwak M. K., Misra V., Biswal S., Yamamoto M., Kensler T. W., Regulation of Notch1 signaling by Nrf2: implications for tissue regeneration. Science Signaling 2010 3 130 ra52 2-s2.0-77956640097 10.1126/scisignal.2000762